SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Misonix Inc. (MSON)
MSON 26.540.0%Nov 22 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rudolf Muenster who wrote (557)12/4/1997 12:37:00 PM
From: spinynorman1323  Read Replies (1) of 947
 
MSON news release.......

Misonix, Inc. Announces Initial Probe Order From United States Surgical
Corporation

PR Newswire - December 04, 1997 12:22

MSON USS %MTC V%PRN P%PRN

Jump to first matched term
Also Receives Additional Order For Ultrasonic Surgical Technology

FARMINGDALE, N.Y., Dec. 4 /PRNewswire/ -- Misonix, Inc. (Nasdaq: MSON)
today announced that the Company has received an initial order from United
States Surgical Corporation (NYSE: USS) for the manufacture of probes to be
used with USS's AutoSonix* cutting device, as well as a follow-up order for
ultrasonic generators and transducers, which are the main components of the
ultrasonic cutting system. The AutoSonix* system uses high-frequency sound
waves to coagulate and divide tissue in both open and laparoscopic surgery.
These orders totaled $3.8 million.
In October 1996, Misonix entered into an exclusive license agreement with
USS covering the further development and commercialization of the Company's
medical technology relating to ultrasonic cutting. The license agreement
gives USS exclusive worldwide marketing and sales rights to this technology.
Dr. Joseph Librizzi, President and Chief Executive Officer of Misonix,
said, "We are pleased with the continued development of our relationship with
U.S. Surgical. With the addition of these two new orders, Misonix has now
received orders from U.S. Surgical totaling over $5 million for its devices
and related products."
Separately, the Company announced that market acceptance of the Lysonix
2000 Ultrasonic Soft Tissue Aspirator remains positive; however, based on
Lysonix's current inventory level, Misonix anticipates that orders will not
resume until the second calendar quarter of 1998.
In December 1995, Misonix entered into a license agreement with Medical
Device Alliance, Inc. (MDA), giving MDA exclusive worldwide marketing and
sales rights for Misonix's ultrasonic soft tissue aspiration medical device.
The device is marketed and sold by Lysonix Inc., a wholly-owned subsidiary of
MDA, under the Lysonix 2000 name.
Misonix, Inc. develops, manufactures, and/or markets medical, scientific,
and industrial ultrasonic and air pollution systems.
United States Surgical Corporation is a diversified surgical products
company specializing in minimally invasive technologies that improve patient
care and lower health care costs.

* Trademark of United States Surgical Corporation.

Forward Looking Statements: Statements in this news release looking
forward in time are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Investors are cautioned that
forward-looking statements involve risks and uncertainties, including general
economic conditions, delays and risks associated with the performance of
contracts, consumer and industry acceptance, and regulatory risks.

SOURCE Misonix, Inc.
/CONTACT: Cheryl Schneider, Tessa Lavender, or Press: Michael McMullan of
Morgen-Walke Associates, 212-850-5600, for Misonix/
(MSON USS)
___________

Mark
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext